Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Venous Thrombosis

  Free Subscription

Articles published in Thromb Haemost

Retrieve available abstracts of 82 articles:
HTML format

Single Articles

    March 2023
    Modern lung scintigraphy techniques for optimising the diagnosis of pulmonary embolism: Great expectations, still waiting to be met.
    Thromb Haemost. 2023 Mar 19. doi: 10.1055/a-2057-8672.
    PubMed     Abstract available

    February 2023
  2. HU S, Tan JS, Hu MJ, Guo TT, et al
    The Causality between Diabetes with Venous Thromboembolism: A Bidirectional Two-sample Mendelian Randomization Study.
    Thromb Haemost. 2023 Feb 22. doi: 10.1055/a-2040-4850.
    PubMed     Abstract available

  3. BIKDELI B, Lo YC, Khairani C, Bejjani A, et al
    Developing Validated Tools to Identify Pulmonary Embolism in Electronic Databases: Rationale and Design of the PE-EHR+ Study.
    Thromb Haemost. 2023 Feb 21. doi: 10.1055/a-2039-3222.
    PubMed     Abstract available

  4. BECATTINI C, Agnelli G, Maggioni AP, Dentali F, et al
    Thromb Haemost. 2023 Feb 9. doi: 10.1055/a-2031-3859.
    PubMed     Abstract available

    January 2023
  5. MARTIN-FERNANDEZ L, Garcia-Martinez I, Lopez S, Martinez-Perez A, et al
    Multiallelic Copy Number Variation in ORM1 is Associated with Plasma Cell-Free DNA Levels as an Intermediate Phenotype for Venous Thromboembolism.
    Thromb Haemost. 2023 Jan 25. doi: 10.1055/s-0043-1760844.
    PubMed     Abstract available

  6. HWANG HG, Lee JH, Bang SM
    Incidence of Pregnancy-associated Venous Thromboembolism: Second Nationwide Study.
    Thromb Haemost. 2023 Jan 24. doi: 10.1055/a-2019-0607.
    PubMed     Abstract available

  7. SCHENKER C, Stalder O, Mean M, Tritschler T, et al
    Bleeding Risk in Elderly Patients with Venous Thromboembolism Who Would Have Been Excluded from Anticoagulation Trials.
    Thromb Haemost. 2023 Jan 9. doi: 10.1055/s-0042-1760365.
    PubMed     Abstract available

    December 2022
  8. GOUALOU M, Noumegni S, de Moreuil C, Le Guillou M, et al
    Venous Thromboembolism Associated with Assisted Reproductive Technology: A Systematic Review and Meta-analysis.
    Thromb Haemost. 2022 Dec 31. doi: 10.1055/s-0042-1760255.
    PubMed     Abstract available

  9. RONNOW SAND J, Troelsen FS, Nagy D, Farkas DK, et al
    Increased Cancer Risk in Patients with Kidney Disease and Venous Thromboembolism: A Population-Based Cohort Study.
    Thromb Haemost. 2022 Dec 27. doi: 10.1055/s-0042-1759879.
    PubMed     Abstract available

  10. MCBANE II RD, Vlazny DT, Houghton D, Casanegra AI, et al
    Survival Implications of Thrombus Recurrence or Bleeding in Cancer Patients Receiving Anticoagulation for Venous Thromboembolism Treatment.
    Thromb Haemost. 2022 Dec 27. doi: 10.1055/s-0042-1758835.
    PubMed     Abstract available

  11. TRZEPIZUR W, Gerves C, Heudes B, Blanchard M, et al
    Sleep apnea and incident unprovoked venous thromboembolism: data from the Pays de la Loire sleep cohort.
    Thromb Haemost. 2022 Dec 19. doi: 10.1055/a-2000-8288.
    PubMed     Abstract available

  12. GRANDONE E, Ageno W
    The legacy of Edwards and Steptoe and the windy roads of Assisted Reproduction: where do we stand with Venous Thromboembolism?
    Thromb Haemost. 2022 Dec 10. doi: 10.1055/a-1996-1341.
    PubMed     Abstract available

    November 2022
  13. SQUIZZATO A, Venturini A, Pelitti V, Bellini B, et al
    Diagnostic accuracy of V/Q and Q SPECT/CT in patients with suspected pulmonary embolism: a systematic review and meta-analysis.
    Thromb Haemost. 2022 Nov 24. doi: 10.1055/a-1986-8878.
    PubMed     Abstract available

  14. TSCHARRE M, Wittmann F, Kitzmantl D, Schloglhofer T, et al
    Impact of ABO Blood Group on Thromboembolic and Bleeding Complications in Patients with Left Ventricular Assist Devices.
    Thromb Haemost. 2022 Nov 19. doi: 10.1055/a-1983-0676.
    PubMed     Abstract available

  15. WANG J, Tan JS, Hua L, Sheng Q, et al
    Genetic predisposition of both waist circumference and hip circumference increased the risk of venous thromboembolism.
    Thromb Haemost. 2022 Nov 16. doi: 10.1055/a-1980-8852.
    PubMed     Abstract available

  16. GURUNATHAN U, Barras M, McDougall C, Nandurkar H, et al
    Obesity and the Risk of Venous Thromboembolism after Major Lower Limb Orthopaedic Surgery: A Literature Review.
    Thromb Haemost. 2022 Nov 16. doi: 10.1055/s-0042-1757200.
    PubMed     Abstract available

    October 2022
  17. SANCHEZ O, Konstantinides SV
    Does Fibrinolytic Strategy of Pulmonary Embolism International ThrOmbolysis (PEITHO)-3 Trial Need More Strong Evidence?
    Thromb Haemost. 2022 Oct 28. doi: 10.1055/s-0042-1756356.

  18. CARMONA-BAYONAS A, Verso M, Sanchez Canovas M, Rubio Perez J, et al
    Do Antiangiogenics Promote Clot Instability? Data from the TESEO Prospective Registry and Caravaggio Clinical Trial.
    Thromb Haemost. 2022;122:1653-1661.
    PubMed     Abstract available

    September 2022
  19. ORDING AG, Skjoth F, Andersen SD, Larsen TB, et al
    Adverse Events and All-Cause Mortality in Danish Patients with Cerebral Venous Thrombosis: A Nationwide Cohort Study.
    Thromb Haemost. 2022;122:1524-1531.
    PubMed     Abstract available

    August 2022
  20. FORET T, Dufrost V, Heymonet M, Risse J, et al
    Circulating endothelial cells are associated with thromboembolic events in patients with antiphospholipid antibodies.
    Thromb Haemost. 2022 Aug 17. doi: 10.1055/a-1926-0453.
    PubMed     Abstract available

    July 2022
  21. GUNER A, Kahraman S, Erturk M
    Does Fibrinolytic Strategy of Pulmonary Embolism International THrOmbolysis (PEITHO)-3 Trial Need More Strong Evidence?
    Thromb Haemost. 2022 Jul 12. doi: 10.1055/a-1897-7141.
    PubMed     Abstract available

  22. GOROG DA, Gue YX, Chao TF, Fauchier L, et al
    Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper.
    Thromb Haemost. 2022 Jul 6. doi: 10.1055/s-0042-1750385.
    PubMed     Abstract available

  23. CHI G, Lee JJ, Sheng S, Marszalek J, et al
    Systematic Review and Meta-Analysis of Thromboprophylaxis with Heparins Following Intracerebral Hemorrhage.
    Thromb Haemost. 2022;122:1159-1168.
    PubMed     Abstract available

    June 2022
  24. MA Z, Sun X, Zhang Y, Li H, et al
    Risk of Thromboembolic Events in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Meta-analysis of Randomized Controlled Trials.
    Thromb Haemost. 2022 Jun 30. doi: 10.1055/s-0042-1749185.
    PubMed     Abstract available

  25. KIM SA, Lee JH, Lee JY, Hwang HG, et al
    Treatment and bleeding complications of cancer-associated venous thromboembolism: A Korean population-based study.
    Thromb Haemost. 2022 Jun 28. doi: 10.1055/a-1886-5991.
    PubMed     Abstract available

  26. NOUMEGNI SR, Mansourati V, Tromeur C, Mao RL, et al
    Risk Factors of Cardiovascular Death after Venous Thromboembolism: Results from a Prospective Cohort Study.
    Thromb Haemost. 2022 Jun 18. doi: 10.1055/s-0042-1748889.
    PubMed     Abstract available

    May 2022
  27. ZHANG YJ, Li ZH, Shen D, Zhang PD, et al
    Association of Combined Lifestyle and Polygenetic Risk with Incidence of Venous Thromboembolism: A Large Population-Based Cohort Study.
    Thromb Haemost. 2022 May 27. doi: 10.1055/s-0042-1744377.
    PubMed     Abstract available

  28. JAKOBSEN L, Frischmuth T, Braekkan SK, Hansen JB, et al
    Joint effect of multiple prothrombotic genotypes and mean platelet volume on the risk of incident venous thromboembolism.
    Thromb Haemost. 2022 May 26. doi: 10.1055/a-1863-2052.
    PubMed     Abstract available

    April 2022
  29. GRIS JR, Bouguignon C, Bouvier S, Cochery-Nouvellon E, et al
    Thromb Haemost. 2022 Apr 26. doi: 10.1055/a-1835-8808.
    PubMed     Abstract available

  30. D'APOLITO M, Ariano A, D'Andrea G, Tiscia G, et al
    Identification of the novel G250R variant indicates a role for Thrombomodulin in modulating the risk for venous thromboembolism.
    Thromb Haemost. 2022 Apr 18. doi: 10.1055/a-1827-7109.
    PubMed     Abstract available

  31. NOPP S, Pabinger I
    Growth Differentiation Factor-15: a Novel Biomarker for Predicting Risk of Venous Thromboembolism and Bleeding in Patients with Cancer.
    Thromb Haemost. 2022 Apr 18. doi: 10.1055/a-1827-7328.
    PubMed     Abstract available

    March 2022
  32. GABET A, Grave C, Tuppin P, Olie V, et al
    One Year Prevalence of Venous Thromboembolism in Hospitalized COVID-19 Patients in France: Patients' Characteristics, Time Trends, and Outcomes.
    Thromb Haemost. 2022 Mar 14. doi: 10.1055/s-0042-1743475.
    PubMed     Abstract available

  33. ROY DC, Wang TF, Mallick R, Carrier M, et al
    GDF-15, hs-TnT and NT proBNP for Predicting Risk of Venous Thromboembolism in Ambulatory Cancer Patients Receiving Chemotherapy.
    Thromb Haemost. 2022 Mar 9. doi: 10.1055/a-1792-7720.
    PubMed     Abstract available

    February 2022
  34. GOLDIN M, Koulas I, Weitz JI, Spyropoulos A, et al
    State-of-the-art-mini review: Dual pathway inhibition to reduce arterial and venous thromboembolism.
    Thromb Haemost. 2022 Feb 21. doi: 10.1055/a-1778-1083.
    PubMed     Abstract available

  35. LECUMBERRI R, Ruiz-Artacho P, Tzoran I, Brenner B, et al
    Outcome of cancer-associated venous thromboembolism is more favorable among patients with hematologic malignancies than in those with solid tumors.
    Thromb Haemost. 2022 Feb 21. doi: 10.1055/a-1777-4006.
    PubMed     Abstract available

  36. PLANQUETTE B, Khider L, Le Berre A, Soudet S, et al
    Adjusting D-dimer to lung disease extent to exclude Pulmonary Embolism in COVID-19 patients (Co-LEAD).
    Thromb Haemost. 2022 Feb 10. doi: 10.1055/a-1768-4371.
    PubMed     Abstract available

    January 2022
  37. RIVAS A, Lauw MN, Bonin-Schnabel R, Crowther M, et al
    Stroke and Thromboembolism in Patients with Heart Failure and Sinus Rhythm: A Matter of Risk Stratification?
    Thromb Haemost. 2022 Jan 19. doi: 10.1055/a-1745-2083.
    PubMed     Abstract available

  38. CHEONG MA, Chew KM
    All that clots is not blood: Bone cement implantation syndrome presenting as an intracardiac mass and pulmonary embolism.
    Thromb Haemost. 2022 Jan 12. doi: 10.1055/a-1738-1777.
    PubMed     Abstract available

  39. BERTOLETTI L, Gusto G, Khachatryan A, Quignot N, et al
    Effectiveness and safety of oral anticoagulants in the treatment of acute venous thromboembolism: A nationwide comparative cohort study in France.
    Thromb Haemost. 2022 Jan 4. doi: 10.1055/a-1731-3922.
    PubMed     Abstract available

    December 2021
  40. FLORIN J, Stalder O, Baumgartner C, Mean M, et al
    Do Patients with a Family or Personal History of Venous Thromboembolism have an Increased Risk of Recurrence?
    Thromb Haemost. 2021 Dec 28. doi: 10.1055/s-0041-1740184.
    PubMed     Abstract available

  41. COHEN AT, Sah J, Dhamane AD, Lee T, et al
    Effectiveness and Safety of Apixaban versus Warfarin in Venous Thromboembolism Patients with Chronic Kidney Disease.
    Thromb Haemost. 2021 Dec 28. doi: 10.1055/s-0041-1740254.
    PubMed     Abstract available

  42. DUBOIS-SILVA A, Barbagelata-Lopez C, Pineiro-Parga P, Francisco I, et al
    Prognostic Significance of Concomitant Superficial Vein Thrombosis in Patients with Deep Vein Thrombosis of the Lower Limbs.
    Thromb Haemost. 2021;121:1650-1659.
    PubMed     Abstract available

    November 2021
  43. ROTHBERG MB, Hamilton A, Greene MT, Fox J, et al
    Derivation and Validation of a Risk Factor Model to Identify Medical Inpatients at Risk for Venous Thromboembolism.
    Thromb Haemost. 2021 Nov 16. doi: 10.1055/a-1698-6506.
    PubMed     Abstract available

  44. EVENSEN LH, Arnesen CAL, Rosendaal FR, Gabrielsen ME, et al
    The risk of venous thromboembolism attributed to established prothrombotic genotypes.
    Thromb Haemost. 2021 Nov 16. doi: 10.1055/a-1698-6717.
    PubMed     Abstract available

  45. ZHOU C, Yi Q, Ge H, Wei H, et al
    Validation of risk assessment models predicting venous thromboembolism in inpatients with AECOPD: a multicenter cohort study.
    Thromb Haemost. 2021 Nov 10. doi: 10.1055/a-1693-0063.
    PubMed     Abstract available

  46. KHAN F, Rahman A, Tritschler T, Carrier M, et al
    Long-term risk of major bleeding after discontinuing anticoagulation for unprovoked venous thromboembolism: a systematic review and meta-analysis.
    Thromb Haemost. 2021 Nov 9. doi: 10.1055/a-1690-8728.
    PubMed     Abstract available

    September 2021
  47. SANCHEZ O, Charles-Nelson A, Ageno W, Barco S, et al
    Reduced-dose intravenous thrombolysis for acute intermediate high-risk pulmonary embolism: Rationale and design of the PEITHO-3 trial.
    Thromb Haemost. 2021 Sep 24. doi: 10.1055/a-1653-4699.
    PubMed     Abstract available

  48. SHARMAN MOSER S, Chodick G, Ni YG, Chalothorn D, et al
    The Association between Factor XI Deficiency and the Risk of Bleeding, Cardiovascular, and Venous Thromboembolic Events.
    Thromb Haemost. 2021 Sep 23. doi: 10.1055/s-0041-1735971.
    PubMed     Abstract available

  49. MAHE I, Agnelli G, Ay C, Bamias A, et al
    Extended Anticoagulant Treatment with Full- or Reduced-Dose Apixaban in Patients with Cancer-Associated Venous Thromboembolism: the API-CAT Study.
    Thromb Haemost. 2021 Sep 17. doi: 10.1055/a-1647-9896.
    PubMed     Abstract available

  50. AGNELLI G, Munoz A, Franco L, Mahe I, et al
    Apixaban and Dalteparin for the Treatment of Venous Thromboembolism in Patients with Different Sites of Cancer.
    Thromb Haemost. 2021 Sep 16. doi: 10.1055/s-0041-1735194.
    PubMed     Abstract available

  51. BIKDELI B, Hogan H, Morrison R, Fanikos J, et al
    Extended-Duration Low-intensity Apixaban to Prevent Recurrence in Patients with Provoked Venous Thromboembolism: Design of the HI-PRO Trial.
    Thromb Haemost. 2021 Sep 16. doi: 10.1055/a-1646-2244.
    PubMed     Abstract available

    August 2021
  52. GABARIN N, Patterson S, Pai M, Afzaal T, et al
    Venous Thromboembolism and Mild Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    Thromb Haemost. 2021 Aug 12. doi: 10.1055/a-1585-6182.
    PubMed     Abstract available

    July 2021
  53. VALERIO L, Fedeli U, Schievano E, Avossa F, et al
    Decline in overall pulmonary embolism-related mortality and increasing prevalence of cancer-associated events in the Veneto region (Italy), 2008-2019.
    Thromb Haemost. 2021 Jul 12. doi: 10.1055/a-1548-4948.
    PubMed     Abstract available

  54. RIEDL JM, Schwarzenbacher E, Moik F, Horvath L, et al
    Patterns of thromboembolism in patients with advanced pancreatic cancer undergoing 1st-line chemotherapy with FOLFIRINOX or Gemcitabine/nab-paclitaxel.
    Thromb Haemost. 2021 Jul 12. doi: 10.1055/a-1548-4847.
    PubMed     Abstract available

  55. NOUMEGNI SR, Hoffmann C, Tromeur C, Didier R, et al
    Risk Factors of Arterial Events in Patients with Venous Thromboembolism: A Systematic Review and Meta-Analysis.
    Thromb Haemost. 2021 Jul 11. doi: 10.1055/s-0041-1732300.
    PubMed     Abstract available

  56. FRISCHMUTH T, Hindberg K, Aukrust P, Ueland T, et al
    Plasma Levels of Leptin and Risk of Future Incident Venous Thromboembolism.
    Thromb Haemost. 2021 Jul 11. doi: 10.1055/s-0041-1732295.
    PubMed     Abstract available

    June 2021
  57. VAN DE BRUG A, De Winter M, Ten Wolde M, Kaasjager K, et al
    Deciding on treatment duration for unprovoked venous thromboembolism: what is important to patients?
    Thromb Haemost. 2021 Jun 24. doi: 10.1055/a-1535-8726.
    PubMed     Abstract available

  58. BONNESEN K, Schmidt M, Horvath-Puho E, Sorensen HT, et al
    The interaction effect between comorbidity and venous thromboembolism on mortality rates after venous thromboembolism: A 5-year cohort study.
    Thromb Haemost. 2021 Jun 11. doi: 10.1055/a-1527-6215.
    PubMed     Abstract available

  59. MORA D, Nieto JA, Mateo J, Bikdeli B, et al
    Machine learning to predict outcomes in patients with acute pulmonary embolism who prematurely discontinued anticoagulant therapy.
    Thromb Haemost. 2021 Jun 9. doi: 10.1055/a-1525-7220.
    PubMed     Abstract available

    May 2021
  60. HENDRIKS S, Bistervels I, Eijsvogel M, Faber L, et al
    Home treatment compared to initial hospitalization in patients with acute pulmonary embolism in the Netherlands: a cost analysis.
    Thromb Haemost. 2021 May 26. doi: 10.1055/a-1518-1847.
    PubMed     Abstract available

  61. FRISCHMUTH T, Hindberg K, Gabrielsen ME, Brumpton BM, et al
    Joint effect of multiple prothrombotic genotypes and obesity on the risk of incident venous thromboembolism.
    Thromb Haemost. 2021 May 3. doi: 10.1055/a-1497-9777.
    PubMed     Abstract available

    April 2021
  62. FREI AN, Stalder O, Limacher A, Mean M, et al
    Comparison of Bleeding Risk Scores in Elderly Patients Receiving Extended Anticoagulation with Vitamin K Antagonists for Venous Thromboembolism.
    Thromb Haemost. 2021 Apr 30. doi: 10.1055/s-0041-1726345.
    PubMed     Abstract available

  63. PASTORI D, Agnelli G
    Risk Scores for Death in Patients with Cancer-related Venous Thromboembolism: Still a Long Road Ahead.
    Thromb Haemost. 2021 Apr 22. doi: 10.1055/s-0041-1727244.

  64. GIRARD P, Laporte S, Chapelle C, Falvo N, et al
    Failure of the Ottawa Score to Predict the Risk of Recurrent Venous Thromboembolism in Cancer Patients: The Prospective PREDICARE Cohort Study.
    Thromb Haemost. 2021 Apr 20. doi: 10.1055/a-1486-7497.
    PubMed     Abstract available

  65. MOOR J, Baumgartner C, Mean M, Stalder O, et al
    Validation of the 2019 European Society of Cardiology risk stratification algorithm for pulmonary embolism in normotensive elderly patients.
    Thromb Haemost. 2021 Apr 6. doi: 10.1055/a-1475-2263.
    PubMed     Abstract available

    February 2021
  66. HOSKIN S, Brieger D, Chow V, Kritharides L, et al
    Trends in Acute Pulmonary Embolism Admission Rates and Mortality Outcomes in Australia, 2002-2003 to 2017-2018: A Retrospective Cohort Study.
    Thromb Haemost. 2021 Feb 28. doi: 10.1055/s-0041-1725932.
    PubMed     Abstract available

  67. HERRERA-RIVERO M, Stoll M, Hegenbarth JC, Ruhle F, et al
    Single- and Multimarker Genome-Wide Scans Evidence Novel Genetic Risk Modifiers for Venous Thromboembolism.
    Thromb Haemost. 2021 Feb 16. doi: 10.1055/s-0041-1723988.
    PubMed     Abstract available

  68. KING A, Leider H, Herman D, Malinowski AK, et al
    Patient- and Health-Care-Provider-Reported Outcomes to Consider in Research on Pregnancy-Associated Venous Thromboembolism.
    Thromb Haemost. 2021 Feb 10. doi: 10.1055/s-0041-1722855.
    PubMed     Abstract available

  69. KUCZMIK W, Wysokinski WE, Hesley GK, Vlazny DT, et al
    Calf Vein Thrombosis Comparison of Outcomes for Axial and Muscular Venous Thrombosis.
    Thromb Haemost. 2021;121:216-223.
    PubMed     Abstract available

    January 2021
  70. COHEN SL, Gianos E, Barish MA, Chatterjee S, et al
    Prevalence and Predictors of Venous Thromboembolism or Mortality in Hospitalized COVID-19 Patients.
    Thromb Haemost. 2021 Jan 20. doi: 10.1055/a-1366-9656.
    PubMed     Abstract available

  71. LI XQ, Hu YH, Lin P, Zhang JR, et al
    Comparison of Different Clinical Prognostic Scores in Patients with Pulmonary Embolism and Active Cancer.
    Thromb Haemost. 2021 Jan 15. doi: 10.1055/a-1355-3549.
    PubMed     Abstract available

  72. ORIONE C, Tromeur C, Le Mao R, Le Floch PY, et al
    The Impact of Pulmonary Vascular Obstruction on the Risk of Recurrence of Pulmonary Embolism: A French Prospective Cohort.
    Thromb Haemost. 2021 Jan 14. doi: 10.1055/s-0040-1722190.
    PubMed     Abstract available

  73. WENDELBOE AM, Campbell J, Ding K, Bratzler DW, et al
    Incidence of Venous Thromboembolism in a Racially Diverse Population of Oklahoma County, Oklahoma.
    Thromb Haemost. 2021 Jan 10. doi: 10.1055/s-0040-1722189.
    PubMed     Abstract available

    December 2020
  74. LE MAO R, Jimenez D, Bikdeli B, Porres-Aguilar M, et al
    Prognostic Impact of Obstructive Sleep Apnea in Patients Presenting with Acute Symptomatic Pulmonary Embolism.
    Thromb Haemost. 2020 Dec 30. doi: 10.1055/s-0040-1721506.
    PubMed     Abstract available

  75. ELIAS A, Aronson D
    Risk of Acute Kidney Injury after Intravenous Contrast Media Administration in Patients with Suspected Pulmonary Embolism: A Propensity-Matched Study.
    Thromb Haemost. 2020 Dec 10. doi: 10.1055/s-0040-1721387.
    PubMed     Abstract available

  76. PROIETTI M, Rivera-Caravaca JM, Esteve-Pastor MA, Marin F, et al
    Stroke and Thromboembolism in Warfarin-Treated Patients with Atrial Fibrillation: Comparing the CHA2DS2-VASc and GARFIELD-AF Risk Scores.
    Thromb Haemost. 2020 Dec 9. doi: 10.1055/a-1333-4448.
    PubMed     Abstract available

    November 2020
  77. ZOLLER BA, Svensson P, Huang W, Ji J, et al
    Reactome pathway analysis of venous thromboembolism, peripheral artery disease, stroke, and coronary artery.
    Thromb Haemost. 2020 Nov 19. doi: 10.1055/a-1315-2307.
    PubMed     Abstract available

  78. SPIRK D, Sebastian T, Barco S, Banyai M, et al
    Clinical Outcomes of Incidental Venous Thromboembolism in Cancer and Noncancer Patients: The SWIss Venous ThromboEmbolism Registry (SWIVTER).
    Thromb Haemost. 2020 Nov 17. doi: 10.1055/s-0040-1720977.
    PubMed     Abstract available

  79. AGENO W, Vedovati MC, Cohen A, Huisman M, et al
    Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio Study.
    Thromb Haemost. 2020 Nov 17. doi: 10.1055/s-0040-1720975.
    PubMed     Abstract available

  80. ZABCZYK M, Natorska J, Janion-Sadowska A, Metzgier-Gumiela A, et al
    Loose Fibrin Clot Structure and Increased Susceptibility to Lysis Characterize Patients with Central Acute Pulmonary Embolism: The Impact of Isolated Embolism.
    Thromb Haemost. 2020 Nov 13. doi: 10.1055/s-0040-1718762.
    PubMed     Abstract available

  81. COHEN A, Keshishian A, Lee T, Wygant G, et al
    Effectiveness and Safety of Apixaban, Low-Molecular-Weight Heparin, and Warfarin among Venous Thromboembolism Patients with Active Cancer: A U.S. Claims Data Analysis.
    Thromb Haemost. 2020 Nov 10. doi: 10.1055/s-0040-1718728.
    PubMed     Abstract available

    October 2020
  82. SCHULMAN S, Hu Y, Konstantinides S
    Venous Thromboembolism in COVID-19.
    Thromb Haemost. 2020 Oct 24. doi: 10.1055/s-0040-1718532.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Venous Thrombosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.